Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Feature article about Theralase on biotuesdays.com website

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jan 08, 2023 7:49pm

256 Views

Post# 35210149

RE:RE:RE:Feature article about Theralase on biotuesdays.com website

Since the company says they plan to apply for BTD sometime in Q1, and since the FDA has to respond within 60 says, that means we'll hear something in early March at the soonest and end of May at the latest. If they apply in Q1 as stated.

What I don't know is if, or how many, rounds of ping pong with the FDA can occur such as them asking for more info or clarifications? Each time that happens is X more weeks for each side? My assumption is the same, I'm hoping to hear something by mid year at the latest.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario